Search

Date 2022 Author/Creator Re, F.

1. P1144: RADIOIMMUNOTHERAPY (RIT) VERSUS AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION (ASCT) IN RELAPSED/REFRACTORY (R/R) FOLLICULAR LYMPHOMA: A FONDAZIONE ITALIANA LINFOMI (FIL) PHASE III TRIAL. (23rd June 2022)

Authors:
Ladetto, M.; Tavarozzi, R.; Evangelista, A.; Zanni, M.; Tucci, A.; Anastasia, A.; Botto, B.; Boccomini, C.; Bolis, S.; Volpetti, S.; Zilioli, V. R.; Puccini, B.; Arcari, A.; Pavone, V.; Gaidano, G.; Corradini, P.; Tani, M.; Ferrero, S.; Cavallo, F.; Milone, G.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1032
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P1256: A NOVEL DROP-OFF DIGITAL PCR ASSAY FOR CXCR4 MUTATION SCREENING IN IGM GAMMOPATHIES: FIRST DATA FROM THE FONDAZIONE ITALIANA LINFOMI BIO-WM STUDY. (23rd June 2022)

Authors:
Drandi, D.; Ferrante, M.; Zibellini, S.; Marcheselli, L.; Cappello, E.; Borriero, M.; Ragaini, S.; Dogliotti, I.; Varraso, C.; Cavallo, F.; Ferrari, A.; Merli, M.; Zamprogna, G.; Laurenti, L.; Tomasetti, S.; Cencini, E.; Loseto, G.; Finotto, S.; Marchetti, M.; Re, F.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1141
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P1450: AUTOLOGOUS STEM CELL TRANSPLANTATION INDUCES HIGHER LEVEL OF EXHAUSTED T-CELLS IN DLBCL PATIENTS BEFORE LEUKAPHERESIS FOR CAR-T CELL THERAPY. (23rd June 2022)

Authors:
Farina, M.; Chiarini, M.; Almici, C.; Beghin, A.; Accorsi Buttini, E.; Galvagni, A.; Ferrari, E.; Bianchetti, A.; Zuccalà, F.; Piva, S.; Volonghi, I.; Poli, L.; Moratto, D.; Leoni, A.; Re, F.; Bosio, K.; Bernardi, S.; Polverelli, N.; Turra, A.; Morello, E.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1332
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. PB2209: HIGH RISK MYELODYSPLASTIC SYNDROME DEVELOPING IN A PATIENT AFTER CHIMERIC ANTIGEN RECEPTOR (CAR) T- CELL THERAPY FOR RELAPSED DIFFUSE LARGE B CELL LYMPHOMA. (23rd June 2022)

Authors:
Accorsi Buttini, E.; Farina, M.; Turra, A.; Morello, E.; Polverelli, N.; Colnaghi, F.; Almici, C.; Ferrari, E.; Bianchetti, A.; Leoni, A.; Re, F.; Bosio, K.; Bernardi, S.; Malagola, M.; Re, A.; Russo, D.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
2079
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. S221: BORTEZOMIB TO R-DHAP COMPARED TO R-DHAP IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA ELIGIBLE TO STEM CELL TRANPLANTATION: FINAL RESULTS OF PHASE II RANDOMIZED FIL-VERAL12. (23rd June 2022)

Authors:
Chiappella, A.; Balzarotti, M.; Botto, B; Castiglione, A.; Cavallo, F.; Usai, S. V.; Zanni, M.; Califano, C.; Re, F.; Ghiggi, C.; Olivieri, A.; Corradini, P.; Liberati, A. M.; Volpetti, S.; Michieli, M. G.; Tucci, A; Gaidano, G.; Tani, M.; Ciambelli, F.; Musuraca, G.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search